Trial | NCT00372008  Report issue

Title

Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
A Phase II Randomised, Two-Way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered-Dose (MD) Lotion Doses in Hypogonadal Male Subjects

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    40
Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this study will evaluate the efficacy and safety of this product.
Study Started
Oct 31
2006
Primary Completion
Apr 30
2007
Study Completion
Apr 30
2007
Last Update
Jun 20
2008
Estimate

Drug Testosterone

Criteria 

Inclusion Criteria:

Hypogonadal males between 18-70 years old with qualifying general medical health

Exclusion Criteria:

Disqualifying concurrent conditions or allergy/sensitivity to testosterone replacement therapy
No Results Posted